Profile
Christopher Tapper currently works at Microbiotica Ltd., as Director from 2020, Exvastat Ltd., as Director from 2020, and Cambridge Innovation Capital Ltd, as Principal.
Mr. Tapper received his undergraduate degree in 2014 from the University of Cambridge.
Christopher Tapper active positions
| Companies | Position | Start |
|---|---|---|
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments. | Private Equity Investor | - |
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Director/Board Member | 01/08/2020 |
Microbiotica Ltd.
Microbiotica Ltd. BiotechnologyHealth Technology Operates research and experimental development on biotechnology | Director/Board Member | 01/09/2020 |
Training of Christopher Tapper
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments. | Finance |
Microbiotica Ltd.
Microbiotica Ltd. BiotechnologyHealth Technology Operates research and experimental development on biotechnology | Health Technology |
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Health Technology |
- Stock Market
- Insiders
- Christopher Tapper
















